Therapeutics

Obalon Schedules Fourth Quarter and Year-End 2019 Financial Results Conference Call for February 27, 2020 at 8:30 a.m. Eastern Time

4 monthes ago   |   By San Diego Biotechnology

SAN DIEGO, Feb. 13, 2020 - Obalon Therapeutics, Inc. , a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, announces th......
Read more ...

 

Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks

Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks

4 monthes ago   |   By Xconomy

Eisai is withdrawing weight-loss drug lorcaserin after a post-marketing study found a higher incidence of cancer in patients who took the medicine. The FDA said Thursday that its request for removal of the product from the market is voluntary, but Eisai has already started the process for doing so. The withdrawal follows an FDA alert issued last month that lorcaserin may contribute to a higher risk of cancer. Lorcaserin was approved in 2012 as a weight management therapy for use in addition to a reduced-calorie diet and exercise. The drug was intended to suppress appetite while avoiding...
Read more ...

 


Search by Tags

   Therapeutics      Obesity      Gas      News      Syndication      Nasdaq      OBLNUS67424L1008      Therapies      Drugs      Cancer      Drug      Medicine      Boston blog main      Boston top stories      Boulder      Denver blog main      Denver top stories      Detroit blog main      Detroit top stories      Europe blog main      Europe top stories      Indiana blog main      Indiana top stories      National      National blog main      National top stories      New York blog main      New York top stories      Raleigh-Durham blog main      Raleigh-Durham top stories      San Diego blog main      San Diego top stories      San Francisco blog main      San Francisco top stories      Seattle blog main      Seattle top stories      Texas blog main      Texas top stories      Wisconsin blog main      Wisconsin top stories      Arena Pharmaceuticals      Biotech      Cancer      Cardiovascular Disease      Clinical trials      Colorectal Cancer      Eisai      FDA      Life Sciences      Lorcaserin      Lung Cancer      Obsesity      Orexigen Therapeutics      Pancreatic Cancer      Product recalls      Vivus  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Foghorn Therapeutics Inks Chromatin-Targeting Cancer Deal with Merck

Foghorn Therapeutics Inks Chromatin-Targeting Cancer Deal with Merck

Foghorn Therapeutics could receive up to $425 million in the development deal with Merck, its first partnership with a major biopharma. One way that a cell regulates which... Read more ...

Sanofi Pays Kymera $150M to Kick Off Protein Degrader Partnership

Sanofi Pays Kymera $150M to Kick Off Protein Degrader Partnership

Kymera Therapeutics has signed a deal with French biopharma Sanofi to advance two potential treatments for immune-inflammatory diseases that leverage the Cambridge, MA-based... Read more ...

Data Migration: Being Prepared

Data Migration: Being Prepared

Our Professional Services Written by: Alan Pham, Business Development Associate In a world where our data is crucial to our everyday lives, implementing new platforms is... Read more ...

NFlection Looks to Erase NF1 Tumors With Drug That Only Goes Skin Deep

NFlection Looks to Erase NF1 Tumors With Drug That Only Goes Skin Deep

The first drug for neurofibromatosis type 1 is available to patients following the FDA's approval of the AstraZeneca treatment earlier this year. Biotech startup NFlection... Read more ...

VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs

VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs

Dave Johnson has known UC San Diego physician and cancer reseacher Thomas Kipps for nearly 20 years. Now Johnson, CEO of San Diego-based cancer drug developer VelosBio, has... Read more ...

Biogen Alzheimer's Drug in FDA's Court Following Completion of Filing

Biogen Alzheimer's Drug in FDA's Court Following Completion of Filing

By early September Biogen-plus the many scientists, patients, and investors following the saga of its controversial Alzheimer's drug aducanamab-should know whether the FDA... Read more ...

The 2020 National Xconomy Awards Expands, Goes Virtual & Reopens Nomination...

The 2020 National Xconomy Awards Expands, Goes Virtual & Reopens Nomination Period

The 2020 National Xconomy Awards - celebrating the best in biotech innovation and entrepreneurship - just got bigger! We're excited to announce the expansion of the 2020... Read more ...

Scientists Dive Deep Into Hidden World of Quantum States

Scientists Dive Deep Into Hidden World of Quantum States

Right: Animation of a Van Hove singularity shown approximately 1 nanometer below the surface of an oxide heterostructure made of atomically thin layers of strontium titanate... Read more ...

UFGI Publication round-up week 7/6/20

Manipulation of sensory characteristics and volatile compounds in strawberry fruit through the use of isolated wavelengths of light. Campbell SM, Sims CA, Bartoshuk LM... Read more ...

DNA Chisel, a versatile sequence optimizer

AbstractMotivationAccounting for biological and practical requirements in DNA sequence design often results in challenging optimization problems. Current software solutions are... Read more ...